Nanalysis Announces Second Quarter 2025 Results
28 augusti, 23:09
28 augusti, 23:09
Nanalysis Announces Second Quarter 2025 Results
PR Newswire
CALGARY, AB, Aug. 28, 2025
CALGARY, AB , Aug. 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30 , 2025. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30 A.M. Eastern Time tomorrow, Friday, August 29th . All interested parties are invited to join these calls. All dollar figures in this press release are in thousands of Canadian dollars, except per share amounts or unless otherwise stated.
"The first half of 2025 has been challenging because of economic uncertainty caused by global tariff and trade conditions. The second quarter reflected lower product sales, which had a direct impact on our financial results," said Sean Krakiwsky , Founder and CEO of Nanalysis. "Even so, our cost reduction and efficiency measures have continued to support stronger margins in the scientific equipment business. In our security services segment, the team's focus on scheduling, logistics, and cost management has led to sequential margin improvement, and we expect these efforts will continue to benefit margins in the coming quarters.
"Our plan remains unchanged, we are focused on building a vertically integrated scientific instrumentation company, advancing our Benchtop NMR platforms, and strengthening our service business. Operational execution and efficiency will remain at the core of how we deliver results as we progress on the path to long-term profitable growth."
Financial highlights for the three months ended June 30, 2025:
Three months ended June 30 | |||||
($000's) | 2025 | 2024 | Change $ | Change % | |
Product sales | 2,902 | 5,402 | (2,500) | -46 % | |
Security services revenue | 5,617 | 5,265 | 352 | 7 % | |
Flow-through inventory revenue | 1,057 | 807 | 250 | 31 % | |
Total sales and revenue | 9,576 | 11,474 | (1,898) | -17 % | |
Gross margin percentage - product sales | 61 % | 50 % | 11 % | ||
Gross margin percentage - service revenue | 10 % | 10 % | 0 % | ||
Adjusted EBITDA | (462) | 759 | (1,221) | ||
Normalized net loss (excludes impairment of assets) | (2,122) | (1,795) | (327) | -18 % | |
Net loss | (2,122) | (1,995) | (127) | -6 % |
Financial highlights for the six months ended June 30, 2025:
Six months ended June 30 | |||||
($000's) | 2025 | 2024 | Change $ | Change % | |
Product sales | 6,589 | 9,618 | (3,029) | -31 % | |
Security services revenue | 10,640 | 9,988 | 652 | 7 % | |
Flow-through inventory revenue | 2,941 | 3,030 | (89) | -3 % | |
Total sales and revenue | 20,170 | 22,636 | (2,466) | -11 % | |
Gross margin percentage - product sales | 64 % | 49 % | 15 % | ||
Gross margin percentage - service revenue | 8 % | 9 % | -1 % | ||
Adjusted EBITDA | (282) | 655 | (937) | ||
Normalized net loss (excludes impairment of assets) | (3,429) | (4,317) | 888 | 21 % | |
Net loss | (3,429) | (4,517) | 1,088 | 24 % |
Quarterly Trend:
($000's) | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Product sales | 2,902 | 3,687 | 5,536 | 4,242 |
Security services revenue | 5,617 | 5,023 | 5,602 | 5,420 |
Flow-through parts revenue | 1,057 | 1,884 | 1,151 | 908 |
Total revenue | 9,576 | 10,594 | 12,289 | 10,570 |
Adjusted EBITDA | (462) | 180 | 1,904 | 545 |
Normalized net loss | (2,122) | (1,307) | (400) | (1,570) |
Recent strategic and operational highlights during and after the second quarter of 2025 include:
Outlook
"As we move into the second half of 2025, we continue to see a solid sales funnel; however, the first half highlighted how tariff risks and broader economic conditions can influence the timing of capital equipment purchases," said Mr. Krakiwsky.
"In the Security Services segment, the team has been implementing efficiency measures introduced in the second quarter, with a focus on scheduling, logistics, and cost management. These efforts, together with ongoing cost control and working capital discipline, are directed at improving operational effectiveness.
"Across both product and services, our focus remains on efficiency, margin improvement, and the continued advancement of our Benchtop NMR platforms and service offerings. The team is committed to process improvements and execution, as we persevere through these difficult economic conditions" added Mr. Krakiwsky.
Conference Call:
Investors interested in participating in the live full year call can dial 437-900-0527 or 1-888-510-2154 from abroad. Investors can also access the call online through a listen-only webcast here https://app.webinar.net/eXAlax953qK or on the investor relations section of the Company's website HERE .
The webcast will be archived on the Company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID #83432.
Additionally, the Company will be hosting a Q&A session for its European investors at 8:30am ET tomorrow, Friday , August 29 th , which can be accessed by the following link: Join the meeting now .
Non-IFRS and Supplementary Financial Measures
The Company prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, as adopted by the Canadian Accounting Standards Board ("IFRS"). However, this press release may make reference to certain non-IFRS measures including key performance indicators used by management. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS.
The Company uses Flow-through parts revenue, Security services revenue, Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"), and Normalized net loss as non-IFRS measures, which may be calculated differently by other companies. These non-IFRS measure are used to provide investors supplemental measures of the Company's operating performance and liquidity and thus highlight trends in the Company's business that may not otherwise be apparent when relying solely on IFRS measures. The Company also believes that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of companies in similar industries.
Flow through parts revenue and Security services revenue
Three months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Security services revenue | 5,617 | 5,265 | 352 | |
Flow-through inventory revenue | 1,057 | 807 | 250 | |
Total Service Revenue | 6,674 | 6,072 | 602 | |
Security services costs | 5,065 | 4,759 | 306 | |
Flow-through inventory costs | 1,057 | 807 | 250 | |
Total Cost of Services | 6,122 | 5,566 | 556 | |
Six months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Security services revenue | 10,640 | 9,988 | 652 | |
Flow-through inventory revenue | 2,941 | 3,030 | (89) | |
Total Service Revenue | 13,581 | 13,018 | 563 | |
Security services costs | 9,789 | 9,114 | 675 | |
Flow-through inventory costs | 2,941 | 3,030 | (89) | |
Total Cost of Services | 12,730 | 12,144 | 586 |
Adjusted EBITDA
Three months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Net loss | (2,122) | (1,995) | (127) | |
Depreciation and amortization expense | 1,051 | 1,154 | (103) | |
Finance expense | 359 | 357 | 2 | |
Stock-based compensation | 112 | 388 | (276) | |
Other (income) expenses | (44) | 350 | (394) | |
Amortization of deferred wages | 216 | 276 | (60) | |
Loss from associate | - | 235 | (235) | |
Current income tax expense | 10 | 2 | 8 | |
Deferred income tax recovery | (44) | (8) | (36) | |
Adjusted EBITDA | (462) | 759 | (1,221) | |
Six months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Net loss | (3,429) | (4,517) | 1,088 | |
Depreciation and amortization expense | 1,975 | 2,306 | (331) | |
Finance expense | 686 | 711 | (25) | |
Stock-based compensation | 243 | 648 | (405) | |
Other (income) expenses | (182) | 604 | (786) | |
Amortization of deferred wages | 406 | 466 | (60) | |
Loss from associate | - | 435 | (435) | |
Current income tax expense | 37 | 34 | 3 | |
Deferred income tax recovery | (18) | (32) | 14 | |
Adjusted EBITDA | (282) | 655 | (937) |
Adjusted EBITDA by Quarter
($000's) | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Net loss | (2,122) | (1,307) | (7,452) | (1,644) |
Depreciation and amortization expense | 1,051 | 924 | 1,155 | 1,165 |
Finance expense | 359 | 327 | 293 | 341 |
Stock-based compensation | 112 | 131 | 199 | 181 |
Other (income) expenses | (44) | (138) | 124 | (94) |
Amortization of deferred wages | 216 | 190 | 215 | 214 |
Loss from associate | - | - | 345 | 305 |
Impairment of assets | - | - | 7,052 | 74 |
Current income tax expense (recovery) | 10 | 27 | 33 | (22) |
Deferred income tax (recovery) expense | (44) | 26 | (60) | 25 |
Adjusted EBITDA | (462) | 180 | 1,904 | 545 |
Normalized net loss
($000's) | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Net loss | (2,122) | (1,307) | (7,452) | (1,644) |
Impairment of assets | - | - | 7,052 | 74 |
Normalized net loss | (2,122) | (1,307) | (400) | (1,570) |
Supplementary Financial Measures
The Company may also use supplementary financial measures which are intended to be disclosed on a periodic basis to depict the historical or expected future financial performance, cash position, or cash flow of the Company, are not a non-IFRS measure, and are not presented in the financial statements. The measures as discussed in this press release include:
About Nanalysis Scientific Corp.(TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. is a scientific instrumentation company with proprietary products and services groups working synergistically. The Company is a leading developer and supplier of cryogen-free portable Nuclear Magnetic Resonance (NMR) spectrometers, with a family of proprietary products that sell around the world in the pharma, biotech, energy, food, chemical, advanced materials, and security verticals, as well as in universities and government labs. Whether it is a new drug being developed, a lithium brine pool sample, polymer analysis, or assessing adulteration in foods, customers use the company's products to identify molecular structure. The Company's products are patent protected and manufactured in-house to protect intellectual property and optimize quality and costs. The Company leverages its technology by selling hardware and software on an original equipment manufacturer (OEM) basis to medical imaging customers. The Company provides services to its customers on its proprietary products, as well as on third-party imaging equipment, such as x-ray scanners in airports, border crossings, consulates, and correctional facilities. In 2022, the company won a $160 million services contract with the Canadian Air Transport Security Authority (CATSA) to service scanning equipment in over 80 Canadian airports: After three years of ramping up, the contract is profitable, and the Company continues to expand its services business.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
SOURCE Nanalysis Scientific Corp.
28 augusti, 23:09
Nanalysis Announces Second Quarter 2025 Results
PR Newswire
CALGARY, AB, Aug. 28, 2025
CALGARY, AB , Aug. 28, 2025 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces second quarter results for the period ending on June 30 , 2025. Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30 A.M. Eastern Time tomorrow, Friday, August 29th . All interested parties are invited to join these calls. All dollar figures in this press release are in thousands of Canadian dollars, except per share amounts or unless otherwise stated.
"The first half of 2025 has been challenging because of economic uncertainty caused by global tariff and trade conditions. The second quarter reflected lower product sales, which had a direct impact on our financial results," said Sean Krakiwsky , Founder and CEO of Nanalysis. "Even so, our cost reduction and efficiency measures have continued to support stronger margins in the scientific equipment business. In our security services segment, the team's focus on scheduling, logistics, and cost management has led to sequential margin improvement, and we expect these efforts will continue to benefit margins in the coming quarters.
"Our plan remains unchanged, we are focused on building a vertically integrated scientific instrumentation company, advancing our Benchtop NMR platforms, and strengthening our service business. Operational execution and efficiency will remain at the core of how we deliver results as we progress on the path to long-term profitable growth."
Financial highlights for the three months ended June 30, 2025:
Three months ended June 30 | |||||
($000's) | 2025 | 2024 | Change $ | Change % | |
Product sales | 2,902 | 5,402 | (2,500) | -46 % | |
Security services revenue | 5,617 | 5,265 | 352 | 7 % | |
Flow-through inventory revenue | 1,057 | 807 | 250 | 31 % | |
Total sales and revenue | 9,576 | 11,474 | (1,898) | -17 % | |
Gross margin percentage - product sales | 61 % | 50 % | 11 % | ||
Gross margin percentage - service revenue | 10 % | 10 % | 0 % | ||
Adjusted EBITDA | (462) | 759 | (1,221) | ||
Normalized net loss (excludes impairment of assets) | (2,122) | (1,795) | (327) | -18 % | |
Net loss | (2,122) | (1,995) | (127) | -6 % |
Financial highlights for the six months ended June 30, 2025:
Six months ended June 30 | |||||
($000's) | 2025 | 2024 | Change $ | Change % | |
Product sales | 6,589 | 9,618 | (3,029) | -31 % | |
Security services revenue | 10,640 | 9,988 | 652 | 7 % | |
Flow-through inventory revenue | 2,941 | 3,030 | (89) | -3 % | |
Total sales and revenue | 20,170 | 22,636 | (2,466) | -11 % | |
Gross margin percentage - product sales | 64 % | 49 % | 15 % | ||
Gross margin percentage - service revenue | 8 % | 9 % | -1 % | ||
Adjusted EBITDA | (282) | 655 | (937) | ||
Normalized net loss (excludes impairment of assets) | (3,429) | (4,317) | 888 | 21 % | |
Net loss | (3,429) | (4,517) | 1,088 | 24 % |
Quarterly Trend:
($000's) | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Product sales | 2,902 | 3,687 | 5,536 | 4,242 |
Security services revenue | 5,617 | 5,023 | 5,602 | 5,420 |
Flow-through parts revenue | 1,057 | 1,884 | 1,151 | 908 |
Total revenue | 9,576 | 10,594 | 12,289 | 10,570 |
Adjusted EBITDA | (462) | 180 | 1,904 | 545 |
Normalized net loss | (2,122) | (1,307) | (400) | (1,570) |
Recent strategic and operational highlights during and after the second quarter of 2025 include:
Outlook
"As we move into the second half of 2025, we continue to see a solid sales funnel; however, the first half highlighted how tariff risks and broader economic conditions can influence the timing of capital equipment purchases," said Mr. Krakiwsky.
"In the Security Services segment, the team has been implementing efficiency measures introduced in the second quarter, with a focus on scheduling, logistics, and cost management. These efforts, together with ongoing cost control and working capital discipline, are directed at improving operational effectiveness.
"Across both product and services, our focus remains on efficiency, margin improvement, and the continued advancement of our Benchtop NMR platforms and service offerings. The team is committed to process improvements and execution, as we persevere through these difficult economic conditions" added Mr. Krakiwsky.
Conference Call:
Investors interested in participating in the live full year call can dial 437-900-0527 or 1-888-510-2154 from abroad. Investors can also access the call online through a listen-only webcast here https://app.webinar.net/eXAlax953qK or on the investor relations section of the Company's website HERE .
The webcast will be archived on the Company's investor relations webpage for at least 90 days, and a telephonic playback will be available for seven days after the conference call by calling 1-888-660-6345 or 289-819-1450, conference ID #83432.
Additionally, the Company will be hosting a Q&A session for its European investors at 8:30am ET tomorrow, Friday , August 29 th , which can be accessed by the following link: Join the meeting now .
Non-IFRS and Supplementary Financial Measures
The Company prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, as adopted by the Canadian Accounting Standards Board ("IFRS"). However, this press release may make reference to certain non-IFRS measures including key performance indicators used by management. These measures are not recognized measures under IFRS and do not have a standardized meaning prescribed by IFRS and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective. Accordingly, these measures should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS.
The Company uses Flow-through parts revenue, Security services revenue, Adjusted Earnings Before Interest, Tax, Depreciation and Amortization ("Adjusted EBITDA"), and Normalized net loss as non-IFRS measures, which may be calculated differently by other companies. These non-IFRS measure are used to provide investors supplemental measures of the Company's operating performance and liquidity and thus highlight trends in the Company's business that may not otherwise be apparent when relying solely on IFRS measures. The Company also believes that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of companies in similar industries.
Flow through parts revenue and Security services revenue
Three months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Security services revenue | 5,617 | 5,265 | 352 | |
Flow-through inventory revenue | 1,057 | 807 | 250 | |
Total Service Revenue | 6,674 | 6,072 | 602 | |
Security services costs | 5,065 | 4,759 | 306 | |
Flow-through inventory costs | 1,057 | 807 | 250 | |
Total Cost of Services | 6,122 | 5,566 | 556 | |
Six months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Security services revenue | 10,640 | 9,988 | 652 | |
Flow-through inventory revenue | 2,941 | 3,030 | (89) | |
Total Service Revenue | 13,581 | 13,018 | 563 | |
Security services costs | 9,789 | 9,114 | 675 | |
Flow-through inventory costs | 2,941 | 3,030 | (89) | |
Total Cost of Services | 12,730 | 12,144 | 586 |
Adjusted EBITDA
Three months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Net loss | (2,122) | (1,995) | (127) | |
Depreciation and amortization expense | 1,051 | 1,154 | (103) | |
Finance expense | 359 | 357 | 2 | |
Stock-based compensation | 112 | 388 | (276) | |
Other (income) expenses | (44) | 350 | (394) | |
Amortization of deferred wages | 216 | 276 | (60) | |
Loss from associate | - | 235 | (235) | |
Current income tax expense | 10 | 2 | 8 | |
Deferred income tax recovery | (44) | (8) | (36) | |
Adjusted EBITDA | (462) | 759 | (1,221) | |
Six months ended June 30 | ||||
($000's) | 2025 | 2024 | ($) Change | |
Net loss | (3,429) | (4,517) | 1,088 | |
Depreciation and amortization expense | 1,975 | 2,306 | (331) | |
Finance expense | 686 | 711 | (25) | |
Stock-based compensation | 243 | 648 | (405) | |
Other (income) expenses | (182) | 604 | (786) | |
Amortization of deferred wages | 406 | 466 | (60) | |
Loss from associate | - | 435 | (435) | |
Current income tax expense | 37 | 34 | 3 | |
Deferred income tax recovery | (18) | (32) | 14 | |
Adjusted EBITDA | (282) | 655 | (937) |
Adjusted EBITDA by Quarter
($000's) | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Net loss | (2,122) | (1,307) | (7,452) | (1,644) |
Depreciation and amortization expense | 1,051 | 924 | 1,155 | 1,165 |
Finance expense | 359 | 327 | 293 | 341 |
Stock-based compensation | 112 | 131 | 199 | 181 |
Other (income) expenses | (44) | (138) | 124 | (94) |
Amortization of deferred wages | 216 | 190 | 215 | 214 |
Loss from associate | - | - | 345 | 305 |
Impairment of assets | - | - | 7,052 | 74 |
Current income tax expense (recovery) | 10 | 27 | 33 | (22) |
Deferred income tax (recovery) expense | (44) | 26 | (60) | 25 |
Adjusted EBITDA | (462) | 180 | 1,904 | 545 |
Normalized net loss
($000's) | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
Net loss | (2,122) | (1,307) | (7,452) | (1,644) |
Impairment of assets | - | - | 7,052 | 74 |
Normalized net loss | (2,122) | (1,307) | (400) | (1,570) |
Supplementary Financial Measures
The Company may also use supplementary financial measures which are intended to be disclosed on a periodic basis to depict the historical or expected future financial performance, cash position, or cash flow of the Company, are not a non-IFRS measure, and are not presented in the financial statements. The measures as discussed in this press release include:
About Nanalysis Scientific Corp.(TSXV: NSCI, OTCQX: NSCIF, FRA:1N1)
Nanalysis Scientific Corp. is a scientific instrumentation company with proprietary products and services groups working synergistically. The Company is a leading developer and supplier of cryogen-free portable Nuclear Magnetic Resonance (NMR) spectrometers, with a family of proprietary products that sell around the world in the pharma, biotech, energy, food, chemical, advanced materials, and security verticals, as well as in universities and government labs. Whether it is a new drug being developed, a lithium brine pool sample, polymer analysis, or assessing adulteration in foods, customers use the company's products to identify molecular structure. The Company's products are patent protected and manufactured in-house to protect intellectual property and optimize quality and costs. The Company leverages its technology by selling hardware and software on an original equipment manufacturer (OEM) basis to medical imaging customers. The Company provides services to its customers on its proprietary products, as well as on third-party imaging equipment, such as x-ray scanners in airports, border crossings, consulates, and correctional facilities. In 2022, the company won a $160 million services contract with the Canadian Air Transport Security Authority (CATSA) to service scanning equipment in over 80 Canadian airports: After three years of ramping up, the contract is profitable, and the Company continues to expand its services business.
Notice regarding Forward Looking Statements and Legal Disclaimer
This news release contains certain "forward-looking statements" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as "anticipates", "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed", "positioned" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
SOURCE Nanalysis Scientific Corp.
Krypto
Krypto
1 DAG %
Senast
Stockholmsbörsen
29 augusti, 18:01
Stockholmsbörsen avslutar fredagen nedåt – har lyst rött hela veckan
Castellum
29 augusti, 17:32
Här är de 15 mest blankade aktierna
Saab
29 augusti, 16:39
Affärsområdeschef i Saab säljer aktier för 4,3 miljoner
OMX Stockholm 30
1 DAG %
Senast
2 625,70